| Titolo |
Pubblicato in |
Anno |
| Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity |
CURRENT TOPICS IN PHARMACOLOGY |
2018 |
| The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism |
ENDOCRINE |
2018 |
| Synergistic effects of PARP inhibitors and ionizing radiation on growth and survival of rhabdomyosarcoma cells |
ANNALS OF ONCOLOGY |
2018 |
| Oral platelet gel supernatant plus supportive medical treatment versus supportive medical treatment in the management of radiation-induced oral mucositis: a matched explorative active control trial by propensity analysis |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS |
2017 |
| HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells |
CANCER LETTERS |
2017 |
| Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2017 |
| Radiation therapy and serum salivary amylase in head and neck cancer |
ONCOTARGET |
2017 |
| Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells |
JOURNAL OF HEMATOLOGY & ONCOLOGY |
2017 |
| Defective DNA repair mechanisms in prostate cancer: impact of olaparib |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
2017 |
| The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma |
JOURNAL OF HEMATOLOGY & ONCOLOGY |
2017 |
| The first negative allosteric modulator for dopamine D2 and D3 receptors, SB269652 may lead to a new generation of antipsychotic drugs |
MOLECULAR PHARMACOLOGY |
2017 |
| Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models |
ONCOTARGET |
2017 |
| The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models |
TUMOR BIOLOGY |
2017 |
| The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study |
EUROPEAN JOURNAL OF HISTOCHEMISTRY |
2017 |
| Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
ONCOTARGET |
2017 |
| Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR ser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy |
ONCOTARGET |
2017 |
| Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage |
ONCOTARGET |
2016 |
| c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines |
RADIATION RESEARCH |
2016 |
| Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: a retrospective study by propensity analysis |
ONCOLOGY LETTERS |
2016 |
| Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population |
MOLECULAR CANCER |
2016 |
